We’ve all witnessed a bad product launch. The product team is stressed. Marketing is worried they won’t have enough leads for sales. And sales feels completely unprepared. Does this sound familiar?


If so, click here to watch our video podcast on how to avoid this predicament. We’ll outline how to effectively launch your new products. The success of the new product sits with the entire organization, not just the product team. All functions must be aligned in order to deliver on the business objectives. We’ll discuss how to get there.


During the show, my co-host George de los Reyes and I will interject the opinions of top executives.  You’ll hear from CEOs on why the interlock process is critical when launching and driving new products. You’ll also hear from sales and marketing leaders to understand their departmental needs. For example, the marketing team needs the right messaging for the launch to be successful.  And the products will not sell themselves. What will the sales team need to convert possible buyers into revenue?


Successfully launching new products is key to revenue growth. Get it wrong, and you’ll miss your number. To get started, watch our video podcast here. It will help you determine if your organization is strategically aligned. And ultimately, ensure you get it right when launching your products.


Matt Sharrers

Studies and works with the top 1% of B2B sales and marketing leaders who generate above average revenue growth for their companies.

Matt is arguably one of the industry’s most connected, and physically fit, sales leaders. He “lives in the field.” As a result, he is the foremost expert in the art of separating fact from fiction as it relates to revenue growth best practices. Because of Matt’s unique access to the best sales talent, private equity investors tend to turn to him first when they need to hire remarkable leaders to unlock trapped growth inside of their portfolio companies. Matt’s recent engagements include work commissioned by private equity leaders Permira, TPG, Bain Capital and Hellman & Friedman.


Read full bio >